School of Medicine

WashU Medicine researchers have discovered that the ratio between two types of white blood cells can predict whether a person stays healthy as they age or faces an increased risk of disease.

A WashU Medicine radiologist is on a mission to expand a minimally invasive procedure called cryoablation as a safe option for patients.

WashU Medicine researchers show in a new study that brain cells called astrocytes modulate the supply of cholesterol in the brain to help neurons communicate.

First-year WashU Medicine MD and MD/PhD students received their white coats at a ceremony Oct. 2. Other ceremonies recognized incoming students studying physical therapy, occupational therapy and audiology.

WashU Medicine researchers have identified a promising approach to treat myeloproliferative neoplasms, a group of chronic blood cancers, by interfering with a protein that drives inflammation.

Biomedical engineer Ismael Seáñez along with collaborators from WashU Medicine will study the effects of delivering transcutaneous spinal cord stimulation only when the person intends to move, thanks to a three-year $400,000 grant from the Craig S. Neilsen Foundation.

WashU Medicine researchers have won a $400,000 prize for creating a free online tool to help scientists track and showcase the real-world value of the raw research data they share with the public.

A grant to WashU Medicine researchers will fund the study of how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.

In a mouse study, WashU Medicine researchers show that a drug injected into the body can reduce damage caused by a protein called tau, which accumulates in the brain in Alzheimer’s and related neurological diseases.

WashU Medicine researchers find that children with more autistic traits favored a brain activity pattern tied to sight and movement before age 9 and one tied to social and emotional processing after 14, suggesting interventions could be tailored by age.